Abstract
The hematopoietic growth factors are glycoproteins that can be produced by recombinant DNA technology. They have many potential clinical uses in acute leukemia; several areas have been explored extensively and much data are available from clinical trials. Other areas are of potential interest, but have a paucity of clinical information. The past decade has seen major strides in the development and clinical application of cytokines in acute leukemia and it is expected that this trend will continue over the next decade as further areas are explored and results of clinical trials mature to enable us to determine the precise role of cytokines in the clinical setting.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rowe, J., Liesveld, J. Hematopoietic growth factors in acute leukemia. Leukemia 11, 328–341 (1997). https://doi.org/10.1038/sj.leu.2400592
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400592
Keywords
This article is cited by
-
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial
BMC Cancer (2008)
-
Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia
Leukemia (2006)
-
Role of cytokines in the treatment of acute leukemias: a review
Leukemia (2006)
-
The use of an insuflon device for the administration of G-CSF in pediatric cancer patients
Supportive Care in Cancer (2006)
-
Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF
Leukemia (2001)